• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2000500 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2020-10-11 Bayer Healthcare LLC Filed 2020-10-21 view
JYSB2000403 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2020-08-21 Pfizer Europe Ma Eeig;Wyeth Farma SA Filed 2020-09-01 view
JXSL1600041 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Import Drug Application 2016-07-11 Bayer Healthcare LLC Certificate Issued 2018-07-27 view
JTS2200019 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Disposable Import Drug Application 2022-04-20 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG;Takeda (China) International Trading Co Ltd view
CYSB2400133 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2024-05-24 SinoCelltech Ltd view
JYSB1000025 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2010-02-09 Bayer Healthcare LLC Certificate Issued 2010-12-27 view
JYSB1900284 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2019-11-22 Baxter AG;Baxalta Manufacturing Sàrl Certificate Issued 2020-01-03 view
JYSB1500135 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2015-05-19 Baxter AG;Baxter Bioscience Manufacturing Sarl Certificate Issued 2017-03-27 view
JYSZ2100536 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2021-12-17 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG;Takeda (China) International Trading Co Ltd view
JYSB2300181 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2023-10-26 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB2101171 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-11-25 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JYSB2500026 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-02-08 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JYSB2000569 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2020-11-18 Baxter AG;Baxalta Manufacturing Sàrl Filed 2020-12-01 view
JYSB2101172 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-11-25 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JYSB2400179 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-08-14 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB1800045 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-03-23 Bayer Healthcare LLC Certificate Issued 2018-07-27 view
JXSS1000006 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Import Drug Application 2010-06-21 Baxter SA;Baxter AG Certificate Issued 2012-05-10 view
JXSS2200004 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.1) Import Drug Application 2022-01-26 Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd view
JXSL2300208 注射用重组单链人凝血因子VIII Lyophilized Biological Products(3.1) Import Drug Application 2023-11-28 Parexel China Co Ltd;Csl Behring GmbH view
JXSL0900029 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Import Drug Application 2009-05-11 Wyeth Pharmaceuticals Inc Certificate Issued 2010-05-27 view